These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35468810)

  • 1. Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows.
    Sobahy TM; Tashkandi G; Bahussain D; Al-Harbi R
    BMC Med Genomics; 2022 Apr; 15(1):95. PubMed ID: 35468810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CACSV: a computational web-sever that provides classification for cancer somatic genetic variants from different tissues.
    AlKurabi N; AlGahtani A; Sobahy TM
    BMC Bioinformatics; 2023 Mar; 24(1):95. PubMed ID: 36922756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants.
    He MM; Li Q; Yan M; Cao H; Hu Y; He KY; Cao K; Li MM; Wang K
    Genome Med; 2019 Aug; 11(1):53. PubMed ID: 31443733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Somatic Curation and Interpretation Across Laboratories (SOCIAL) project-current state of solid-tumour variant interpretation for molecular pathology in Canada.
    Spence T; Sukhai MA; Kamel-Reid S; Stockley TL
    Curr Oncol; 2019 Dec; 26(6):353-360. PubMed ID: 31896933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of challenges and a framework for implementation of the AMP/ASCO/CAP classification guidelines for reporting somatic variants.
    Parikh BA; Love-Gregory L; Duncavage EJ; Heusel JW
    Pract Lab Med; 2020 Aug; 21():e00170. PubMed ID: 32548229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best Practice for Clinical Somatic Variant Interpretation and Reporting.
    Schubert J; Wu J; Li MM; Cao K
    Clin Lab Med; 2022 Sep; 42(3):423-434. PubMed ID: 36150821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.
    Li MM; Datto M; Duncavage EJ; Kulkarni S; Lindeman NI; Roy S; Tsimberidou AM; Vnencak-Jones CL; Wolff DJ; Younes A; Nikiforova MN
    J Mol Diagn; 2017 Jan; 19(1):4-23. PubMed ID: 27993330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessments of Somatic Variant Classification Using the Association for Molecular Pathology/American Society of Clinical Oncology/College of American Pathologists Guidelines: A Report from the Association for Molecular Pathology.
    Li MM; Cottrell CE; Pullambhatla M; Roy S; Temple-Smolkin RL; Turner SA; Wang K; Zhou Y; Vnencak-Jones CL
    J Mol Diagn; 2023 Feb; 25(2):69-86. PubMed ID: 36503149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Predisposition Sequencing Reporter (CPSR): A flexible variant report engine for high-throughput germline screening in cancer.
    Nakken S; Saveliev V; Hofmann O; Møller P; Myklebost O; Hovig E
    Int J Cancer; 2021 Dec; 149(11):1955-1960. PubMed ID: 34310709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors: American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathology guideline.
    Leighl NB; Rekhtman N; Biermann WA; Huang J; Mino-Kenudson M; Ramalingam SS; West H; Whitlock S; Somerfield MR
    J Clin Oncol; 2014 Nov; 32(32):3673-9. PubMed ID: 25311215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CancerVar: An artificial intelligence-empowered platform for clinical interpretation of somatic mutations in cancer.
    Li Q; Ren Z; Cao K; Li MM; Wang K; Zhou Y
    Sci Adv; 2022 May; 8(18):eabj1624. PubMed ID: 35544644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome analysis and knowledge-driven variant interpretation with TGex.
    Dahary D; Golan Y; Mazor Y; Zelig O; Barshir R; Twik M; Iny Stein T; Rosner G; Kariv R; Chen F; Zhang Q; Shen Y; Safran M; Lancet D; Fishilevich S
    BMC Med Genomics; 2019 Dec; 12(1):200. PubMed ID: 31888639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update.
    Kalemkerian GP; Narula N; Kennedy EB; Biermann WA; Donington J; Leighl NB; Lew M; Pantelas J; Ramalingam SS; Reck M; Saqi A; Simoff M; Singh N; Sundaram B
    J Clin Oncol; 2018 Mar; 36(9):911-919. PubMed ID: 29401004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New workflow for classification of genetic variants' pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID).
    Van Gijn ME; Ceccherini I; Shinar Y; Carbo EC; Slofstra M; Arostegui JI; Sarrabay G; Rowczenio D; Omoyımnı E; Balci-Peynircioglu B; Hoffman HM; Milhavet F; Swertz MA; Touitou I
    J Med Genet; 2018 Aug; 55(8):530-537. PubMed ID: 29599418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer.
    Sirohi D; Schmidt RL; Aisner DL; Behdad A; Betz BL; Brown N; Coleman JF; Corless CL; Deftereos G; Ewalt MD; Fernandes H; Hsiao SJ; Mansukhani MM; Murray SS; Niu N; Ritterhouse LL; Suarez CJ; Tafe LJ; Thorson JA; Segal JP; Furtado LV
    J Mol Diagn; 2020 Feb; 22(2):284-293. PubMed ID: 31837433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internal Standardization of the Interpretation and Reporting of Sequence Variants in Hematologic Neoplasms.
    Mehta N; He R; Viswanatha DS
    Mol Diagn Ther; 2021 Jul; 25(4):517-526. PubMed ID: 34125426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology.
    Sepulveda AR; Hamilton SR; Allegra CJ; Grody W; Cushman-Vokoun AM; Funkhouser WK; Kopetz SE; Lieu C; Lindor NM; Minsky BD; Monzon FA; Sargent DJ; Singh VM; Willis J; Clark J; Colasacco C; Rumble RB; Temple-Smolkin R; Ventura CB; Nowak JA
    J Clin Oncol; 2017 May; 35(13):1453-1486. PubMed ID: 28165299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection.
    Atkins A; Gupta P; Zhang BM; Tsai WS; Lucas J; Javey M; Vora A; Mei R
    Mol Diagn Ther; 2019 Aug; 23(4):521-535. PubMed ID: 31209714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants.
    Brandt T; Sack LM; Arjona D; Tan D; Mei H; Cui H; Gao H; Bean LJH; Ankala A; Del Gaudio D; Knight Johnson A; Vincent LM; Reavey C; Lai A; Richard G; Meck JM
    Genet Med; 2020 Feb; 22(2):336-344. PubMed ID: 31534211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.